ATE353231T1 - Pharmazeutische zusammensetzungen - Google Patents
Pharmazeutische zusammensetzungenInfo
- Publication number
- ATE353231T1 ATE353231T1 AT03793261T AT03793261T ATE353231T1 AT E353231 T1 ATE353231 T1 AT E353231T1 AT 03793261 T AT03793261 T AT 03793261T AT 03793261 T AT03793261 T AT 03793261T AT E353231 T1 ATE353231 T1 AT E353231T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical compositions
- asthma
- preparing
- processes
- treatment
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229960002744 mometasone furoate Drugs 0.000 abstract 1
- WOFMFGQZHJDGCX-ZULDAHANSA-N mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/001—Particle size control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49826—Assembling or joining
- Y10T29/49908—Joining by deforming
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Organic Chemistry (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40556302P | 2002-08-23 | 2002-08-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE353231T1 true ATE353231T1 (de) | 2007-02-15 |
Family
ID=31946896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03793261T ATE353231T1 (de) | 2002-08-23 | 2003-08-21 | Pharmazeutische zusammensetzungen |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20040086465A1 (de) |
| EP (1) | EP1542753B1 (de) |
| JP (2) | JP2005536538A (de) |
| AT (1) | ATE353231T1 (de) |
| AU (1) | AU2003259986A1 (de) |
| CA (1) | CA2495689A1 (de) |
| DE (1) | DE60311665T2 (de) |
| ES (2) | ES2281691T3 (de) |
| MX (1) | MXPA05002060A (de) |
| WO (1) | WO2004018025A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2495689A1 (en) * | 2002-08-23 | 2004-03-04 | Schering Corporation | Pharmaceutical compositions |
| ATE384001T1 (de) * | 2002-08-27 | 2008-02-15 | Schering Corp | Verfahren zur herstellung von dosierinhalatorformulierungen |
| CN1870976A (zh) * | 2003-10-20 | 2006-11-29 | 先灵公司 | 药物组合物 |
| PT1711164E (pt) * | 2004-01-21 | 2010-06-28 | Schering Corp | Método de tratamento da rinossinusite aguda |
| MX2007001561A (es) * | 2004-08-04 | 2007-04-16 | Schering Corp | Formulacion farmaceutica que comprende pleconaril para tratamiento de enfermedades de vias aereas. |
| EP1981545A2 (de) * | 2006-02-09 | 2008-10-22 | Schering Corporation | Pharmazeutische formulierungen |
| WO2008057248A2 (en) | 2006-10-26 | 2008-05-15 | Next Breath Llc | Phospholipid-based inhalation system |
| US20080253970A1 (en) * | 2007-02-09 | 2008-10-16 | Schering Corporation | Stable Pharmaceutical Drug Products |
| GB0714239D0 (en) * | 2007-07-20 | 2007-08-29 | Glaxo Group Ltd | Method |
| SI3106149T1 (sl) | 2009-05-29 | 2020-07-31 | Pearl Therapeutics, Inc. | Sestavki za pljučno dostavo muskarinskih antagonistov z dolgotrajnim delovanjem in agonistov beta-2 adrenergičnega receptorja z dolgotrajnim delovanjem in povezani postopki in sistemi |
| ATE539148T1 (de) * | 2009-11-30 | 2012-01-15 | United Cancer Res Inst | Neuer klon des geflügelpestvirus, herstellung und anwendung bei der medizinischen behandlung von krebs |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5474759A (en) * | 1991-06-10 | 1995-12-12 | Schering Corporation | Non-chlorofluorocarbon aerosol formulations |
| US6524557B1 (en) * | 1994-12-22 | 2003-02-25 | Astrazeneca Ab | Aerosol formulations of peptides and proteins |
| CN1088580C (zh) * | 1994-12-22 | 2002-08-07 | 阿斯特拉公司 | 气溶胶药物制剂 |
| US6068832A (en) * | 1996-08-29 | 2000-05-30 | Schering Corporation | Chlorofluorocarbon-free mometasone furoate aerosol formulations |
| CN1162157C (zh) * | 1996-08-29 | 2004-08-18 | 先灵公司 | 无氯氟烃的糠酸莫米他松气溶胶制剂 |
| WO2000030654A1 (en) * | 1998-11-26 | 2000-06-02 | Britannia Pharmaceuticals Limited | Anti-asthmatic combinations comprising surface active phospholipids |
| EP1263491A2 (de) * | 2000-03-01 | 2002-12-11 | Glaxo Group Limited | Dosierbarer inhalator |
| CA2417973A1 (en) * | 2000-08-04 | 2002-02-14 | Longwood Pharmaceutical Research, Inc. | Formulations of mometasone and a bronchodilator for pulmonary administration |
| CA2425035A1 (en) * | 2000-10-09 | 2002-04-18 | 3M Innovative Properties Company | Medicinal aerosol formulations |
| TWI324934B (en) * | 2001-08-28 | 2010-05-21 | Schering Corp | Pharmaceutical compositions for the treatment of asthma |
| CA2495689A1 (en) * | 2002-08-23 | 2004-03-04 | Schering Corporation | Pharmaceutical compositions |
| ATE384001T1 (de) * | 2002-08-27 | 2008-02-15 | Schering Corp | Verfahren zur herstellung von dosierinhalatorformulierungen |
| US20080253970A1 (en) * | 2007-02-09 | 2008-10-16 | Schering Corporation | Stable Pharmaceutical Drug Products |
-
2003
- 2003-08-21 CA CA002495689A patent/CA2495689A1/en not_active Abandoned
- 2003-08-21 AT AT03793261T patent/ATE353231T1/de not_active IP Right Cessation
- 2003-08-21 ES ES03793261T patent/ES2281691T3/es not_active Expired - Lifetime
- 2003-08-21 JP JP2004529822A patent/JP2005536538A/ja active Pending
- 2003-08-21 MX MXPA05002060A patent/MXPA05002060A/es active IP Right Grant
- 2003-08-21 DE DE60311665T patent/DE60311665T2/de not_active Expired - Lifetime
- 2003-08-21 EP EP03793261A patent/EP1542753B1/de not_active Expired - Lifetime
- 2003-08-21 WO PCT/US2003/026272 patent/WO2004018025A1/en not_active Ceased
- 2003-08-21 ES ES06026917T patent/ES2388537T3/es not_active Expired - Lifetime
- 2003-08-21 AU AU2003259986A patent/AU2003259986A1/en not_active Abandoned
- 2003-08-22 US US10/646,298 patent/US20040086465A1/en not_active Abandoned
-
2006
- 2006-08-10 JP JP2006218995A patent/JP2006312649A/ja active Pending
-
2009
- 2009-12-22 US US12/645,183 patent/US20100095963A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1542753A1 (de) | 2005-06-22 |
| EP1542753B1 (de) | 2007-02-07 |
| JP2006312649A (ja) | 2006-11-16 |
| MXPA05002060A (es) | 2005-06-08 |
| CA2495689A1 (en) | 2004-03-04 |
| US20040086465A1 (en) | 2004-05-06 |
| ES2281691T3 (es) | 2007-10-01 |
| US20100095963A1 (en) | 2010-04-22 |
| ES2388537T3 (es) | 2012-10-16 |
| AU2003259986A1 (en) | 2004-03-11 |
| WO2004018025A1 (en) | 2004-03-04 |
| DE60311665D1 (de) | 2007-03-22 |
| DE60311665T2 (de) | 2007-10-25 |
| JP2005536538A (ja) | 2005-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA04001875A (es) | Composiciones farmaceuticas para el tratamiento de asma. | |
| NO20062504L (no) | Sammensetninger og doseringsformer for forbedret absorpsjon | |
| IL164135A (en) | 4-anilino quinazoline derivatives as antiproliferative agents, process for their preparation, pharmaceutical compositions containing such derivatives and use thereof for the preparation of medicaments for the treatment of cancer | |
| WO2007149406A8 (en) | Modified coagulation factor ix polypeptides and use thereof for treatment | |
| SE0301700D0 (sv) | Novel compounds | |
| WO2004006858A3 (en) | Compounds, compositions, and methods employing same | |
| UA86063C2 (ru) | Липосомы для снабжения лекарств | |
| AU2002218167A1 (en) | N-phenyl-2-pyrimidine-amine derivatives | |
| IL164896A (en) | Pharmaceutical compositions comprising immunoconjugates for the treatment of tumors | |
| PL374443A1 (en) | Novel pyrimidineamide derivatives and the use thereof | |
| YU87202A (sh) | Derivati arilmetilamina koji se koriste kao inhibitori triptaze | |
| SE0302139D0 (sv) | Novel compounds | |
| DE60311665D1 (de) | Pharmazeutische zusammensetzungen | |
| IL157540A0 (en) | N-(aryl)-2-arylethenesulphonamides and therapeutic uses thereof | |
| WO2004091591A3 (fr) | Composition nutritionnelle ou therapeutique contenant le compose oleurofeine ou l'un de ses derives | |
| ATE497967T1 (de) | Interzelluläre kommunikation erleichternden verbindungen und deren medizinischen verwendungen | |
| WO2003053960A3 (en) | Quinline derivates and their use as mek inhibitors | |
| MXPA04005552A (es) | Analogos de vitamina d. | |
| SE0200657D0 (sv) | Novel Formulation | |
| AU2003281193A1 (en) | Quinazoline derivatives for use in the treatment of cancer | |
| WO2005030142A8 (en) | Rifalazil formulations | |
| TWI347845B (en) | Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same | |
| DK1273301T3 (da) | Farmaceutiske præparater baseret på aktive bestanddele der kan anvendes til ulovlig administration | |
| PT1406859E (pt) | Derivados substituídos de 4-aminociclo-hexanol | |
| SE0103210D0 (sv) | New formulations and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |